Personal information

Websites & social links

Intensive Care Medicine Bern University Hopsital
Linkedin
Google Scholar

Keywords

Bacteriophage, Staphylococcus, Pseudomonas aeruginosa, Endocarditis, Antibiotic resistance, Ventilator associated pneumonia

Countries

Switzerland

Activities

Collapse all

Employment (9)

Universitat Bern: Bern, Bern, CH

Employment
Source: check_circle
University of Bern

Inselspital Universitätsspital Bern: Bern, BE, CH

2016-04-01 to present | Associate Professor and Senior Physician (Department of Intensive Care Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2013-10-01 to 2016-03-31 | Privat Docent, Senior Lecturer and Senior Physician (Department of Adult Intensive Care Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2011-01-01 to 2013-09-30 | Senior Lecturer Attending Physician (Department of Adult Intensive Care Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Massachusetts General Hospital: Boston, MA, US

2009-01-01 to 2010-12-31 | Research Fellow (MGH Molecular Surgical Laboratory)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2007-01-01 to 2008-12-31 | Senior Lecturer Attending Physician (Department of Adult Intenisve Care Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2003-04-01 to 2006-02-28 | Chef de Clinique (-adjoint) (Department of Intensive Care Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2000-10-01 to 2003-03-31 (Department of Internal Medicine)
Employment
Source: Self-asserted source
Yok-Ai Que

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

1997-10-01 to 2000-09-30 | PhD Studen (Department of Infectious Diseases)
Employment
Source: Self-asserted source
Yok-Ai Que

Education and qualifications (6)

FMH - Swiss Medical Association: Bern, CH

2011-02-24 to present | FMH Internal Medicine
Qualification
Source: Self-asserted source
Yok-Ai Que

FMH - Swiss Medical Association: Bern, CH

2006-02-16 to present | FMH Intensive Care Medicine
Qualification
Source: Self-asserted source
Yok-Ai Que

Universite de Lausanne: Lausanne, VD, CH

2001-01-26 to present | MD-PhD
Education
Source: Self-asserted source
Yok-Ai Que

Université de Lausanne Faculté de biologie et médecine: Lausanne, VD, CH

1999-01-12 to present | MD
Education
Source: Self-asserted source
Yok-Ai Que

Université de Lausanne Faculté de biologie et médecine: Lausanne, VD, CH

1996-12-20 to present | Federal Diploma of Medicine
Education
Source: Self-asserted source
Yok-Ai Que

University of Bern: Bern, CH

2018-04 to 2021-05-01 | Master of Advanced Studies in Translational and Biomedical Entrepreneurship
Education
Source: Self-asserted source
Yok-Ai Que

Professional activities (5)

Société Suisse de Médecine Intensive: Basel, CH

2006-02-01 to present | Regular
Membership
Source: Self-asserted source
Yok-Ai Que

Swiss Medical Association: Bern, CH

1997-01-01 to present | Regular
Membership
Source: Self-asserted source
Yok-Ai Que

Universite de Lausanne: Lausanne, VD, CH

2001-10 | Prix de La Société Académique Vaudoise - Lauréat de l'Université
Distinction
Source: Self-asserted source
Yok-Ai Que

Université de Lausanne Faculté de biologie et médecine: Lausanne, VD, CH

1999-12 | Prix de Faculté
Distinction
Source: Self-asserted source
Yok-Ai Que

University of Lausanne: Lausanne, CH

1997-12 | Prix de la Commune d'Ecublens
Distinction
Source: Self-asserted source
Yok-Ai Que

Funding (13)

What’s in a dose? Refining phage and antibiotic dosing for effective treatment of multidrug resistant bacterial infections

2022-11-01 to 2026-10-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.13041940
GRANT_NUMBER: 212584
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

Phage Therapy in Humans: Overview on Current Concepts in Europe and the Middle East

2022-08-01 to 2022-10-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.12948163
GRANT_NUMBER: 213476
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

Prophylaxis and Treatment of Staphylococcus spp. Intravascular and Extravascular Infections with Bacteriophages

2018-02-01 to 2022-01-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.7388373
GRANT_NUMBER: 176216
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

Prophylaxis and Treatment of Staphylococcus spp. Pneumonia and Catheter-related Infections with Bacteriophages

2018 to 2019 | Grant
Novartis Foundation for medical-biological research (Basel, CH)
GRANT_NUMBER:

#18A054
Source: Self-asserted source
Yok-Ai Que

In silico prediction of phage-bacteria infection networks as a tool to implement personalized phage therapy

2016-07-01 to 2019-12-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5492813
GRANT_NUMBER: 166124
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

SwissPhage: Therapeutic Phage Library.

2015 to 2018 | Grant
LOTERIE ROMANDE (Lausanne, CH)
Source: Self-asserted source
Yok-Ai Que

Evaluation of a new bacteriophage cocktail for the treatment of acinetobacter baumannii associated experimental bacteremia

2014-05-01 to 2016-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5230664
GRANT_NUMBER: 152319
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

The Comback of Bacteriophages: Meeting with a Bacteria Killer!

2014-05-01 to 2016-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5230072
GRANT_NUMBER: 151512
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

MicroscapesX: Design and Systems Biology of Functional Microbial Landscapes.

2014 to 2016 | Grant
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Bern, CH)
GRANT_NUMBER:

51RTP0_151038
Source: Self-asserted source
Yok-Ai Que

Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa burn wound infections (Phase I-II clinical trial)

2013-06-01 to 2017-02-28 | Grant
European Commission (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.3795854
GRANT_NUMBER: 601857
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

B5 Platform: Biological, Biodegradable, anti-Bacterial, Burn-wound, Bandanges.

2013 to 2016 | Grant
Rectors' Conference of the Swiss Universities (Bern, CH)
GRANT_NUMBER:

#14/2013
Source: Self-asserted source
Yok-Ai Que

Sepsis in Burns: from Epidemiology and Diagnosis to Immunogenetics and Microbial Pathogenesis

2009-01-01 to 2010-12-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5223834
GRANT_NUMBER: 123226
Source: Self-asserted source
Yok-Ai Que via DimensionsWizard

L’infection grave en soins intensifs: Registre Romand Sepsis

2009 to 2013 | Grant
LOTERIE ROMANDE (Lausanne, CH)
Source: Self-asserted source
Yok-Ai Que

Works (50 of 113)

Items per page:
Page 1 of 3

Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study

The Journal of Heart and Lung Transplantation
2023-10 | Journal article
DOI: 10.1016/j.healun.2023.05.016
Contributors: Melissa Pitton; Luca G. Valente; Simone Oberhaensli; Carlo Casanova; Parham Sendi; Bruno Schnegg; Stephan M. Jakob; David R. Cameron; Yok-Ai Que; Monika Fürholz
Source: check_circle
Crossref

Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis.

Infection
2023-09-14 | Journal article
DOI: 10.1007/s15010-023-02093-w
PMID: 37707744
Contributors: Zuercher P; Moser A; Garcia de Guadiana-Romualdo L; Llewelyn MJ; Graf R; Reding T; Eggimann P; Que YA; Prazak J
Source: Self-asserted source
Yok-Ai Que

Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.

American journal of respiratory and critical care medicine
2023-03-01 | Journal article
DOI: 10.1164/rccm.202207-1393oc
PMID: 36215036
Contributors: Shekar K; Abdul-Aziz MH; Cheng V; Burrows F; Hergen Buscher; Young-Jae Cho; Corley A; Diehl A; Gilder E; Jakob SM et al.
Source: Self-asserted source
Yok-Ai Que

Prognostic models in COVID-19 infection that predict severity: a systematic review.

European journal of epidemiology
2023-02-25 | Journal article
DOI: 10.1007/s10654-023-00973-x
PMID: 36840867
PMC: PMC9958330
Contributors: Buttia C; Llanaj E; Raeisi-Dehkordi H; Kastrati L; Amiri M; Meçani R; Taneri PE; Ochoa SAG; Raguindin PF; Wehrli F et al.
Source: Self-asserted source
Yok-Ai Que

The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.

Journal of critical care
2023-01-23 | Journal article
DOI: 10.1016/j.jcrc.2023.154257
PMID: 36696827
Contributors: Zuercher P; André Moser; Frey MC; Pagani JL; Buetti N; Eggimann P; Daneman N; Fowler R; Que YA; Prazak J
Source: Self-asserted source
Yok-Ai Que

A PREVENTIVE TOOL FOR PREDICTING BLOODSTREAM INFECTIONS IN CHILDREN WITH BURNS.

Shock (Augusta, Ga.)
2023-01-04 | Journal article
DOI: 10.1097/shk.0000000000002075
PMID: 36597771
Contributors: Tsurumi A; Flaherty PJ; Que YA; Ryan CM; Banerjee A; Chakraborty A; Almpani M; Shankar M; Goverman J; Schulz JT 3rd et al.
Source: Self-asserted source
Yok-Ai Que

Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.

Respiration; international review of thoracic diseases
2022-12-23 | Journal article
DOI: 10.1159/000528611
PMID: 36566741
PMC: PMC9932828
Contributors: Alexandra Lenoir; Christe A; Ebner L; Beigelman-Aubry C; Pierre-Olivier Bridevaux; Martin Brutsche; Clarenbach C; Berra Erkosar; Garzoni C; Geiser T et al.
Source: Self-asserted source
Yok-Ai Que

Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak

Microbiology Spectrum
2022-12-21 | Journal article
DOI: 10.1128/spectrum.02743-22
Contributors: David R. Cameron; Melissa Pitton; Simone Oberhaensli; Katja Schlegel; Guy Prod’hom; Dominique S. Blanc; Stephan M. Jakob; Yok-Ai Que; Joanna B. Goldberg
Source: check_circle
Crossref

Ten-year retrospective cohort analysis of ventricular assist device infections.

Artificial organs
2022-12-07 | Journal article
DOI: 10.1111/aor.14477
PMID: 36478260
Contributors: giancarlo Spano; Buffle E; Walti LN; Mihalj M; Cameron DR; Martinelli M; Fürholz M; Que YA; Christopher Hayward; Reineke D et al.
Source: Self-asserted source
Yok-Ai Que

Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.

Influenza and other respiratory viruses
2022-11-16 | Journal article
DOI: 10.1111/irv.13059
PMID: 36394086
PMC: PMC9835444
Contributors: Frederike Waldeck; Boroli F; Zingg S; Walti LN; Wendel-Garcia PD; Conen A; Pagani JL; Boggian K; Schnorf M; Siegemund M et al.
Source: Self-asserted source
Yok-Ai Que

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis.

The Lancet. Microbe
2022-11-10 | Journal article
DOI: 10.1016/s2666-5247(22)00288-9
PMID: 36370748
Contributors: Sergio Alejandro Gómez Ochoa; Pitton M; Valente LG; Sosa Vesga CD; Largo J; Quiroga-Centeno AC; Juliana Alexandra Hernández Vargas; Silvia Juliana Trujillo Cáceres; Taulant Muka; Cameron DR et al.
Source: Self-asserted source
Yok-Ai Que

Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance

Antimicrobial Agents and Chemotherapy
2022-07-19 | Journal article
DOI: 10.1128/aac.00621-22
Contributors: Melissa Pitton; Simone Oberhaensli; Fiona Appiah; Jean-Luc Pagani; Anne Fournier; Stephan M. Jakob; Yok-Ai Que; David R. Cameron
Source: check_circle
Crossref

Subtherapeutic doses of vancomycin synergize with bacteriophages for treatment of experimental methicillin-resistant Staphylococcus aureus infective endocarditis

2022-06-04 | Preprint
DOI: 10.1101/2022.06.02.494631
Contributors: Jonathan Save; Yok-Ai Que; José M. Entenza; Grégory Resch
Source: check_circle
Crossref

Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model.

PloS one
2022-04-26 | Journal article
DOI: 10.1371/journal.pone.0266928
PMID: 35472061
PMC: PMC9041855
Source: Self-asserted source
Yok-Ai Que

Frailty assessment for COVID-19 follow-up: a prospective cohort study.

BMJ open respiratory research
2022-04-01 | Journal article
DOI: 10.1136/bmjresp-2022-001227
PMID: 35459694
PMC: PMC9035838
Source: Self-asserted source
Yok-Ai Que

Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis

Journal of the American Heart Association
2022-02 | Journal article
DOI: 10.1161/JAHA.121.023080
Contributors: Jonathan Save; Yok‐Ai Que; José M. Entenza; Camille Kolenda; Frédéric Laurent; Grégory Resch
Source: check_circle
Crossref

mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.

Intensive care medicine
2022-01-20 | Journal article
DOI: 10.1007/s00134-021-06610-z
PMID: 35050384
PMC: PMC8771617
Source: Self-asserted source
Yok-Ai Que

Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)

International Journal of Antimicrobial Agents
2021-12 | Journal article
DOI: 10.1016/j.ijantimicag.2021.106466
Contributors: Vesa Cheng; Mohd H. Abdul-Aziz; Fay Burrows; Hergen Buscher; Amanda Corley; Arne Diehl; Stephan M. Jakob; Bianca J. Levkovich; Vincent Pellegrino; Yok-Ai Que et al.
Source: check_circle
Crossref

Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland.

Critical care explorations
2021-10-11 | Journal article
DOI: 10.1097/cce.0000000000000552
PMID: 34651139
PMC: PMC8509991
Source: Self-asserted source
Yok-Ai Que

CAR T-cell therapy and critical care : A survival guide for medical emergency teams.

Wiener klinische Wochenschrift
2021-10-06 | Journal article
DOI: 10.1007/s00508-021-01948-2
PMID: 34613477
Source: Self-asserted source
Yok-Ai Que

Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA.

BMC research notes
2021-09-27 | Journal article
DOI: 10.1186/s13104-021-05796-1
PMID: 34579784
PMC: PMC8474762
Source: Self-asserted source
Yok-Ai Que

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).

Antimicrobial agents and chemotherapy
2021-08-30 | Journal article
DOI: 10.1128/aac.01438-21
PMID: 34460303
Source: Self-asserted source
Yok-Ai Que

Near real-time observation reveals increased prevalence of young patients in the ICU during the emerging third SARS-CoV-2 wave in Switzerland.

Swiss medical weekly
2021-07-21 | Journal article
DOI: 10.4414/smw.2021.20553
PMID: 34291810
Source: Self-asserted source
Yok-Ai Que

Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis.

Digestive diseases and sciences
2021-07-15 | Journal article
DOI: 10.1007/s10620-021-07152-6
PMID: 34268662
Source: Self-asserted source
Yok-Ai Que

Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.

Swiss medical weekly
2021-06-25 | Journal article
DOI: 10.4414/smw.2021.20529
PMID: 34233009
Source: Self-asserted source
Yok-Ai Que

Short-Course Versus Long-Course Systemic Antibiotic Treatment for Uncomplicated Intravascular Catheter-Related Bloodstream Infections due to Gram-Negative Bacteria, Enterococci or Coagulase-Negative Staphylococci: A Systematic Review.

Infectious diseases and therapy
2021-06-25 | Journal article
DOI: 10.1007/s40121-021-00464-0
PMID: 34169480
Source: Self-asserted source
Yok-Ai Que

Antimicrobial Peptide Dendrimers and Quorum-Sensing Inhibitors in Formulating Next-Generation Anti-Infection Cell Therapy Dressings for Burns.

Molecules (Basel, Switzerland)
2021-06-24 | Journal article
DOI: 10.3390/molecules26133839
PMID: 34202446
Source: Self-asserted source
Yok-Ai Que

Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis.

Critical care (London, England)
2021-05-28 | Journal article
DOI: 10.1186/s13054-021-03609-2
PMID: 34049579
PMC: PMC8164316
Source: Self-asserted source
Yok-Ai Que

Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.

Critical care (London, England)
2021-04-20 | Journal article
DOI: 10.1186/s13054-021-03576-8
PMID: 33879189
PMC: PMC8056692
Source: Self-asserted source
Yok-Ai Que

Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis

FEMS Microbes
2021-04-13 | Journal article
DOI: 10.1093/femsmc/xtab003
Part of ISSN: 2633-6685
Source: Self-asserted source
Yok-Ai Que

Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review.

Critical care explorations
2021-03-08 | Journal article
DOI: 10.1097/cce.0000000000000351
PMID: 33786430
PMC: PMC7994034
Source: Self-asserted source
Yok-Ai Que

Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA): an experimental study in rats.

The Journal of infectious diseases
2021-03-01 | Journal article
DOI: 10.1093/infdis/jiab112
PMID: 33668071
Source: Self-asserted source
Yok-Ai Que

Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study.

The European respiratory journal
2021-01-08 | Journal article
DOI: 10.1183/13993003.03690-2020
PMID: 33419891
Source: Self-asserted source
Yok-Ai Que

Chlorhexidine-dress related contact dermatitis-the precautionary principle is no more relevant!

Critical care (London, England)
2020-12-09 | Journal article
DOI: 10.1186/s13054-020-03411-6
PMID: 33298125
PMC: PMC7724789
Source: Self-asserted source
Yok-Ai Que

Multi-Biomarker Prediction Models for Multiple Infection Episodes Following Blunt Trauma.

iScience
2020-10-07 | Journal article
DOI: 10.1016/j.isci.2020.101659
PMID: 33047099
PMC: PMC7539926
Source: Self-asserted source
Yok-Ai Que

Nebulized Bacteriophages for Prophylaxis of Experimental Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.

Critical care medicine
2020-04-16 | Journal article
DOI: 10.1097/ccm.0000000000004352
PMID: 32304419
Source: Self-asserted source
Yok-Ai Que

Bacteriophages improve outcomes in experimental staphylococcus aureus ventilator-associated pneumonia

American Journal of Respiratory and Critical Care Medicine
2019 | Journal article
DOI: 10.1164/rccm.201812-2372OC
EID:

2-s2.0-85072822451
Contributors: Prazak, J.; Iten, M.; Cameron, D.R.; Save, J.; Grandgirard, D.; Resch, G.; Goepfert, C.; Leib, S.L.; Takala, J.; Jakob, S.M. et al.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study

Clinical Microbiology and Infection
2019 | Journal article
DOI: 10.1016/j.cmi.2019.06.028
EID:

2-s2.0-85069743753
Contributors: Boschung-Pasquier, L.; Atkinson, A.; Kastner, L.K.; Banholzer, S.; Haschke, M.; Buetti, N.; Furrer, D.I.; Hauser, C.; Jent, P.; Que, Y.A. et al.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Draft Genome Sequence of Methicillin-Resistant Staphylococcus aureus Strain AW7, Isolated from a Patient with Bacteremia

Microbiology Resource Announcements
2019 | Journal article
DOI: 10.1128/MRA.00806-19
EID:

2-s2.0-85072830698
Contributors: Cameron, D.R.; Ramette, A.; Prazak, J.; Entenza, J.; Haenggi, M.; Que, Y.-A.; Resch, G.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

The Lancet Infectious Diseases
2019 | Journal article
DOI: 10.1016/S1473-3099(18)30482-1
EID:

2-s2.0-85058276087
Contributors: Jault, P.; Leclerc, T.; Jennes, S.; Pirnay, J.P.; Que, Y.-A.; Resch, G.; Rousseau, A.F.; Ravat, F.; Carsin, H.; Le Floch, R. et al.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia

Journal of Global Antimicrobial Resistance
2019 | Journal article
DOI: 10.1016/j.jgar.2019.05.005
EID:

2-s2.0-85074526964
Contributors: Leshkasheli, L.; Kutateladze, M.; Balarjishvili, N.; Bolkvadze, D.; Save, J.; Oechslin, F.; Que, Y.-A.; Resch, G.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Exploration of multiclass and one-class learning methods for prediction of phage-bacteria interaction at strain level

Proceedings - 2018 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2018
2019 | Conference paper
DOI: 10.1109/BIBM.2018.8621433
EID:

2-s2.0-85062520628
Contributors: Leite, D.M.C.; Lopez, J.F.; Brochet, X.; Barreto-Sanz, M.; Que, Y.-A.; Resch, G.; Pena-Reyes, C.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Measurement of pancreatic stone protein in the identification and management of sepsis

Biomarkers in Medicine
2019 | Journal article
DOI: 10.2217/bmm-2018-0194
EID:

2-s2.0-85062329131
Contributors: Eggimann, P.; Que, Y.-A.; Rebeaud, F.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years

Intensive Care Medicine
2019 | Journal article
DOI: 10.1007/s00134-019-05617-x
EID:

2-s2.0-85064619251
Contributors: Eggimann, P.; Pagani, J.-L.; Dupuis-Lozeron, E.; Ms, B.E.; Thévenin, M.-J.; Joseph, C.; Revelly, J.-P.; Que, Y.-A.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Associations between clinical characteristics and the development of multiple organ failure after severe burns in adult patients

Burns
2019-12 | Journal article
DOI: 10.1016/j.burns.2019.02.014
Contributors: Asako Ogura; Amy Tsurumi; Yok-Ai Que; Marianna Almpani; Hui Zheng; Ronald G. Tompkins; Colleen M. Ryan; Laurence G. Rahme
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Computational prediction of inter-species relationships through omics data analysis and machine learning

BMC Bioinformatics
2018 | Journal article
DOI: 10.1186/s12859-018-2388-7
EID:

2-s2.0-85056742763
Contributors: Leite, D.M.C.; Brochet, X.; Resch, G.; Que, Y.-A.; Neves, A.; Peña-Reyes, C.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Impact of real-time therapeutic drug monitoring on the prescription of antibiotics in burn patients requiring admission to the intensive care unit

Antimicrobial Agents and Chemotherapy
2018 | Journal article
DOI: 10.1128/AAC.01818-17
EID:

2-s2.0-85042401030
Contributors: Fournier, A.; Eggimann, P.; Pantet, O.; Pagani, J.L.; Dupuis-Lozeron, E.; Pannatier, A.; Sadeghipour, F.; Voirol, P.; Que, Y.-A.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations

Virulence
2018 | Journal article
DOI: 10.1080/21505594.2018.1528845
EID:

2-s2.0-85054892589
Contributors: Mancini, S.; Oechslin, F.; Menzi, C.; Que, Y.A.; Claes, J.; Heying, R.; Veloso, T.R.; Vanassche, T.; Missiakas, D.; Schneewind, O. et al.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Population pharmacokinetic study of amoxicillin-treated burn patients hospitalized at a swiss tertiary-care center

Antimicrobial Agents and Chemotherapy
2018 | Journal article
DOI: 10.1128/AAC.00505-18
EID:

2-s2.0-85052244884
Contributors: Fournier, A.; Goutelle, S.; Que, Y.-A.; Eggimann, P.; Pantet, O.; Sadeghipour, F.; Voirol, P.; Csajka, C.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier

Reply to sorooshian and snow, "is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"

Antimicrobial Agents and Chemotherapy
2018 | Journal article
DOI: 10.1128/AAC.01209-18
EID:

2-s2.0-85053918775
Contributors: Fournier, A.; Eggimann, P.; Pantet, O.; Pagani, J.L.; Dupuis-Lozeron, E.; Pannatier, A.; Sadeghipour, F.; Voirol, P.; Que, Y.-A.
Source: Self-asserted source
Yok-Ai Que via Scopus - Elsevier
Items per page:
Page 1 of 3
How many people are using ORCID?